Bank Of New Hampshire Amgen Inc Transaction History

Bank Of New Hampshire

$398 Million
Q3 2024

A detailed history of Bank Of New Hampshire transactions in Amgen Inc stock. As of the latest transaction made, Bank Of New Hampshire holds 1,563 shares of AMGN stock, worth $413,397. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,563

Previous 1,597 2.13%

Holding current value

$413,397

Previous $498,000 1.0%

% of portfolio

0.13%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $10,518 - $11,470	-34 Reduced 2.13%	1,563 $503,000
Q2 2024 Jul 01, 2024	SELL	$262.75 - $319.31 $21,282 - $25,864	-81 Reduced 4.83%	1,597 $498,000
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $42,481 - $51,280	-158 Reduced 8.61%	1,678 $477,000
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $116,087 - $130,960	-454 Reduced 19.83%	1,836 $528,000
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $19,678 - $24,431	-90 Reduced 3.78%	2,290 $615,000
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $11,784 - $13,935	-55 Reduced 2.26%	2,380 $528,000
Q1 2023 Apr 04, 2023	SELL	$225.79 - $275.2 $7,676 - $9,356	-34 Reduced 1.38%	2,435 $588,000
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $10,764 - $13,677	-47 Reduced 1.87%	2,469 $648,000
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $9,651 - $10,885	-43 Reduced 1.68%	2,516 $567,000
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $30,915 - $34,403	-134 Reduced 4.98%	2,559 $623,000
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $877 - $970	-4 Reduced 0.15%	2,693 $651,000
Q4 2021 Jan 12, 2022	SELL	$198.88 - $227.6 $836,688 - $957,513	-4,207 Reduced 60.94%	2,697 $606,000
Q2 2021 Jul 06, 2021	BUY	$233.58 - $259.14 $1.61 Million - $1.79 Million	6,904 New	6,904 $1.68 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.

Account

Bank Of New Hampshire Amgen Inc Transaction History